Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Bone marrow versus peripheral blood sibling transplants in acquired aplastic anemia: survival advantage for marrow in all age groups.

    ... (RR 1.6, p=0.0001), a conditioning regimen other than cyclophosphamide (RR=1.3, p=0.008) and the use of peripheral blood as a ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. Young Aplastic Anemia Patient Grateful That Life is Returning to Normal

    ... receiving immunosuppressive therapy as well as high dose cyclophosphamide (Cytoxan ®) which is given through a fine tube that goes ... every day and today, I’m doing better. I am no longer on cyclophosphamide – just immunosuppressive therapy (when I’m not feeling ...

    Patient Chronicle last updated 04/26/2018 - 12:44pm.

  3. Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome

    ... rapidly among older adults. Modern post-transplant cyclophosphamide (PTCy) protocols with haploidentical (haplo) donors have ...

    Research Article last updated 11/14/2017 - 10:09am.

  4. Rational Management Approach To Pure Red Cell Aplasia

    ... overall RR (response rate) of 76% (53/70). Oral cyclophosphamide showed activity albeit lower than cyclosporine . ...

    Research Article last updated 12/14/2017 - 10:12am.

  5. "Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution.

    ... line therapy of aplastic anemia with high dose cyclophosphamide causes toxicity and increased short-term mortality. We investigated cyclophosphamide at a lower "moderate" dose, in combination with aggressive ...

    Research Article last updated 10/07/2014 - 8:33am.

  6. Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia

    ... Here, we employed post-transplantation high-dose cyclophosphamide in an effort to safely expand the donor pool in 16 ... antithymocyte globulin , fludarabine , low-dose cyclophosphamide, and total body irradiation. Post-transplantation cyclophosphamide 50 mg/kg/day i.v. on days +3 and +4 was administered for ...

    Research Article last updated 01/24/2017 - 10:04am.

  7. High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia

    ... OBJECTIVE: Use of high-dose cyclophosphamide without hematopoietic stem cell transplant to ... than 22 years of age treated with 29 courses of high-dose cyclophosphamide as the sole form of immunosuppression. STUDY DESIGN: ...

    Research Article last updated 11/01/2016 - 1:49pm.

  8. High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia

    ... OBJECTIVE: Use of high-dose cyclophosphamide without hematopoietic stem cell transplant to ... than 22 years of age treated with 29 courses of high-dose cyclophosphamide as the sole form of immunosuppression. STUDY DESIGN: ...

    Research Article last updated 08/15/2016 - 11:49am.

  9. Haploidentical transplant in patients with myelodysplastic syndrome

    ... transplant and 102 patients received posttransplant cyclophosphamide (PT-CY) as graft-versus-host disease (GVHD) ...

    Research Article last updated 10/04/2017 - 9:19am.

  10. Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation.

    ... regimen consisting of fludarabine (F-araA) and cyclophosphamide (Cy) is associated with improved outcome in young patients ...

    Research Article last updated 05/22/2017 - 10:32am.